HIGHLIGHTS
- who: . and colleagues from the University of Medicine and Pharmacy of Sapienza University of Rome, Italy have published the research: Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis, in the Journal: (JOURNAL) of 30/09/2021
- what: Eligible studies in the meta-analysis Four studies provided the information of margin resection. This study compared the clinical effect of neoadjuvant imatinib and upfront surgery on GIST. In current meta-analysis, four studies reported the duration of neoadjuvant imatinib which ranged from 6.3 to 10 months (median . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.